Jesus Gonzalez-Lugo

Assistant Professor

University of Kansas Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jesus Gonzalez-Lugo is an Assistant Professor at The University of Kansas Medical Center, USA. His research focuses on hematologic malignancies, specifically myelodysplastic syndrome, and the effects of various treatment modalities. He has contributed to numerous publications addressing topics such as allogeneic hematopoietic stem cell transplantation, COVID-19 vaccination outcomes in cancer patients, and advancements in epigenetic therapy.

Articles (14)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Abdul Hamid Bazarbachi

Columbia University Irving Medical Center

UNITED STATES

View details

Ladan Golestaneh

UNITED STATES

View details

Astha Thakkar

University of North Carolina

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jesus Gonzalez-Lugo

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review.

Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysis.

Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.

High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination.

Targeting inflammation in lower-risk MDS.

Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer.

Seroconversion rates following COVID-19 vaccination among patients with cancer.

Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational Cohort.

Low ADAMTS13 Activity Correlates with Increased Mortality in COVID-19 Patients.

The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia.

Understanding FLT3 Inhibitor Resistance to Rationalize Combinatorial AML Therapies.

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.

Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).

A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19.

Collaborators (3)

Abdul Hamid Bazarbachi

Ladan Golestaneh

Astha Thakkar

Make your next move.